Biofarma Group

Activities: Manufacturing Drug Delivery

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
  3. LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
  4. Memel Biotech and Therabest collaborate to develop exosome-based cell therapies The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
  5. Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Research & Development

Batavia Biosciences receives $8 million grant to develop rotavirus vaccine

Will develop a low-cost manufacturing process using novel technologies in partnership with Bio Farma
Manufacturing

ProBioGen signs biosimilar deal with Bio Farma Indonesia

German CDMO will develop Trastuzumab and transfer the manufacturing process for first on-site production in Indonesia
Media

Indonesia is becoming a global vaccine player, but so is China

Growing affluence is allowing the government to pour more money into developing a universal healthcare system
Pharmaceutical

Bio Farma launches pentavalent vaccine

Protects babies from five diseases
Manufacturing

ARTES Biotechnology to collaborate with Bio Farma on vaccine development

First agreement for VLP-based vaccine technology transfer signed on 1 July in Bandung
Subscribe now